We observed that bone morphogenetic protein 4 (BMP4) delivery and thymosine β4 targeting display anti-tumor activity in colorectal (CR) cancer by inducing CR-CSC differentiation and inhibition of PI3K/AKT pathway through the contribution of PTEN upregulation [212,213]. Here, AKT1 is linked to neoplasm.